CIK 0001759655 · Large accelerated filer
Privia Health Group, Inc.
Sign in to watch- Ticker
- PRVA
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 571-366-8850
- Business address
- 950 N. GLEBE RD., SUITE 700, ARLINGTON, VA, 22203
- Former names
- PH Group Parent Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-04 | Mountcastle David EVP & Chief Financial Officer | Option exercise 10b5-1 | +1,206 | $2.00 | $2K | 216,053 |
| 2026-05-04 | Mountcastle David EVP & Chief Financial Officer | Sale 10b5-1 | −1,206 | $25.00 | $30K | 214,847 |
| 2026-05-04 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −202 | 1,336 | ||
| 2026-05-04 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −52 | 1,001 | ||
| 2026-05-04 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −592 | 8,897 | ||
| 2026-05-04 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −360 | 5,962 | ||
| 2026-05-04 | Morris Matthew Shawn Director | Option exercise 10b5-1 | +1,017 | $2.00 | $2K | 69,205 |
| 2026-05-04 | Morris Matthew Shawn Director | Sale 10b5-1 | −1,017 | $24.96 | $25K | 68,188 |
| 2026-05-04 | Morris Matthew Shawn Director | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −1,017 | 3,674,201 | ||
| 2026-05-01 | Mountcastle David EVP & Chief Financial Officer | Option exercise 10b5-1 | +7,179 | $2.00 | $14K | 222,026 |
| 2026-05-01 | Mountcastle David EVP & Chief Financial Officer | Sale 10b5-1 | −7,179 | $25.03 | $180K | 214,847 |
| 2026-05-01 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −1,297 | 1,538 | ||
| 2026-05-01 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −541 | 1,053 | ||
| 2026-05-01 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −3,010 | 9,489 | ||
| 2026-05-01 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −2,331 | 6,322 | ||
| 2026-05-01 | Morris Matthew Shawn Director | Option exercise 10b5-1 | +17,096 | $2.00 | $34K | 85,284 |
| 2026-05-01 | Morris Matthew Shawn Director | Sale 10b5-1 | −17,096 | $24.99 | $427K | 68,188 |
| 2026-05-01 | Morris Matthew Shawn Director | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −17,096 | 3,675,218 | ||
| 2026-04-02 | Mountcastle David EVP & Chief Financial Officer | Sale | −5,566 | $20.85 | $116K | 214,847 |
| 2026-03-16 | Mehrotra Parth Chief Executive Officer | Sale | −26,509 | $22.11 | $586K | 555,443 |
Page 3 of 11 · 214 trades